Solutions to TB and HIV benefit all of us
Global funding for neglected disease basic research and product development has declined by more than 20% since it peaked in 2018.
By Monicah Otieno
Mar. 10, 2025
Premium
Once beaten, twice shy: Industry tracks RBZ currency benchmarks
Business
By Concilia Mupezeni and Blessed Ndlovu
Mar. 8, 2026




